Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has raised $12.3 million in an oversubscribed Series D financing round led by River Cities Capital (River Cities) and Mutual Capital Partners (Mutual Capital).

Catalyst OrthoScience is disrupting the usual approaches to shoulder replacement surgery. Founded in 2014 by orthopedic surgeon Steven Goldberg, M.D., the company’s goal is to develop innovative medical solutions that make orthopedic surgery less invasive and more efficient for both surgeons and patients. The company has a growing portfolio of patents and pending patents on its distinctive surgical offerings. Headquartered in Naples, Fla., Catalyst products are available across the U.S. For more information, visit www.CatalystOrtho.com.

Catalyst Orthoscience Announces $12.3 Million Oversubscribed Financing Round To Fuel Company Momentum In Shoulder Arthroplasty

Description

Company Information

Funding Insights

Catalyst Orthoscience Announces $12.3 Million Oversubscribed Financing Round To Fuel Company Momentum In Shoulder Arthroplasty

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information